About Prime Medicine, Inc. Common Stock
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.
Market Cap
$0.26B
Employees
214
Listed Since
October 20, 2022
Industry
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Website
www.primemedicine.comPhone
617-465-0013
Headquarters
60 FIRST ST.
CAMBRIDGE, MA 02141
CIK
0001894562